Yi-Ying Wu - JoVE Visualize

Showing results (181-190 of 205) with videos related to

Pageof 21

Sort By:

Journal of Medical Screening|April 22, 2016

Evaluation issues in the Swedish Two-County Trial of breast cancer screening: An historical reviewLaszlo Tabar, Tony Hsiu-Hsi Chen, Chen-Yang Hsu, et al.

American Journal of Respiratory and Critical Care Medicine|September 13, 2008

Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinomaYu-Chih Chao, Szu-Hua Pan, Shuenn-Chen Yang, et al.

Veterinary Microbiology|November 26, 2021

Molecular chaperone TRiC governs avian reovirus replication by protecting outer-capsid protein σC and inner core protein σA and non-structural protein σNS from ubiquitin- proteasome degradationWei-Ru Huang, Jyun-Yi Li, Tsai-Ling Liao, et al.

Cancers|July 16, 2020

Precision Science on Incidence and Progression of Early-Detected Small Breast Invasive Cancers by Mammographic FeaturesRene Wei-Jung Chang, Shu-Lin Chuang, Chen-Yang Hsu, et al.

Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|December 3, 2014

Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole versus fluconazole in allogeneic blood hematopoietic stem cell transplantation recipients-A retrospective analysis of a single medical center in TaiwanChing-Hsun Wang, Li-Ping Kan, Hsin-An Lin, et al.

Journal of Oncology|May 17, 2019

Imaging Biomarkers as Predictors for Breast Cancer DeathWendy Yi-Ying Wu, Laszlo Tabar, Tibor Tot, et al.

Cell Death & Disease|October 6, 2021

Aberrantly reduced expression of miR-342-5p contributes to CCND1-associated chronic myeloid leukemia progression and imatinib resistanceYi-Ying Wu, Hsing-Fan Lai, Tzu-Chuan Huang, et al.

Journal of Experimental & Clinical Cancer Research : CR|February 4, 2023

MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transitionSheng-Yen Hsiao, Shang-Mei Weng, Jenn-Ren Hsiao, et al.

Journal of Clinical Medicine|April 23, 2022

Phase I Targeted Combination Trial of Sorafenib and GW5074 in Patients with Advanced Refractory Solid TumorsChien-Chang Kao, Ching-Liang Ho, Ming-Hsin Yang, et al.

European Journal of Radiology|August 5, 2023

Imaging biomarkers are underutilised but highly predictive prognostic factors for the more fatal breast cancer subtypesLászló Tabár, Peter B Dean, F Lee Tucker, et al.

Pageof 21

Showing results (181-190 of 205) with videos related to

Sort By:

Pageof 21

Journal of Medical Screening|April 22, 2016

Evaluation issues in the Swedish Two-County Trial of breast cancer screening: An historical reviewLaszlo Tabar, Tony Hsiu-Hsi Chen, Chen-Yang Hsu, et al.

American Journal of Respiratory and Critical Care Medicine|September 13, 2008

Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinomaYu-Chih Chao, Szu-Hua Pan, Shuenn-Chen Yang, et al.

Veterinary Microbiology|November 26, 2021

Molecular chaperone TRiC governs avian reovirus replication by protecting outer-capsid protein σC and inner core protein σA and non-structural protein σNS from ubiquitin- proteasome degradationWei-Ru Huang, Jyun-Yi Li, Tsai-Ling Liao, et al.

Cancers|July 16, 2020

Precision Science on Incidence and Progression of Early-Detected Small Breast Invasive Cancers by Mammographic FeaturesRene Wei-Jung Chang, Shu-Lin Chuang, Chen-Yang Hsu, et al.

Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|December 3, 2014

Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole versus fluconazole in allogeneic blood hematopoietic stem cell transplantation recipients-A retrospective analysis of a single medical center in TaiwanChing-Hsun Wang, Li-Ping Kan, Hsin-An Lin, et al.

Journal of Oncology|May 17, 2019

Imaging Biomarkers as Predictors for Breast Cancer DeathWendy Yi-Ying Wu, Laszlo Tabar, Tibor Tot, et al.

Cell Death & Disease|October 6, 2021

Aberrantly reduced expression of miR-342-5p contributes to CCND1-associated chronic myeloid leukemia progression and imatinib resistanceYi-Ying Wu, Hsing-Fan Lai, Tzu-Chuan Huang, et al.

Journal of Experimental & Clinical Cancer Research : CR|February 4, 2023

MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transitionSheng-Yen Hsiao, Shang-Mei Weng, Jenn-Ren Hsiao, et al.

Journal of Clinical Medicine|April 23, 2022

Phase I Targeted Combination Trial of Sorafenib and GW5074 in Patients with Advanced Refractory Solid TumorsChien-Chang Kao, Ching-Liang Ho, Ming-Hsin Yang, et al.

European Journal of Radiology|August 5, 2023

Imaging biomarkers are underutilised but highly predictive prognostic factors for the more fatal breast cancer subtypesLászló Tabár, Peter B Dean, F Lee Tucker, et al.

Pageof 21